bioAffinity Technologies annual operating margin
2022
2023
2024
2025
bioAffinity Technologies's operating margin was −171.58% for fiscal 2025.
View full bioAffinity Technologies company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −171.58% | −75.94 pp |
| 2024 | 2024-12-31 | −95.64% | +219.20 pp |
| 2023 | 2023-12-31 | −314.84% | +83196.68 pp |
| 2022 | 2022-12-31 | −83,511.51% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −220.77% | −22.61 pp |
| Q1 2026 | 2026-03-31 | −267.62% | −125.89 pp |
| Q4 2025 | 2025-12-31 | −196.94% | −63.47 pp |
| Q3 2025 | 2025-09-30 | −158.56% | −74.58 pp |
| Q2 2025 | 2025-06-30 | −198.16% | −111.08 pp |
| Q1 2025 | 2025-03-31 | −141.73% | −60.90 pp |
| Q4 2024 | 2024-12-31 | −133.47% | −27.64 pp |
| Q3 2024 | 2024-09-30 | −83.98% | +684.74 pp |
| Q2 2024 | 2024-06-30 | −87.08% | +8922.70 pp |
| Q1 2024 | 2024-03-31 | −80.84% | +169079.86 pp |
| Q4 2023 | 2023-12-31 | −105.83% | +84777.30 pp |
| Q3 2023 | 2023-09-30 | −768.72% | +51614.05 pp |
| Q2 2023 | 2023-06-30 | −9,009.78% | — |
| Q1 2023 | 2023-03-31 | −169,160.69% | — |
| Q3 2022 | 2022-09-30 | −84,883.13% | — |
| Q2 2022 | 2022-06-30 | −52,382.77% | — |
Across the available reported history, bioAffinity Technologies's operating margin decreased from −95.64% to −171.58%, a change of −75.94 percentage points. The latest reported quarter, Q2 2026, shows −220.77%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review bioAffinity Technologies filings at SEC.gov ↗